we have provided quantitative estimates of SARSCoV2 infections in vaccinated patients with MPN revealing a higher rate of severe disease than in the normal population. Compared to unvaccinated, a trend for a lower reinfection rate was found in patients with hybrid vaccination.

Breakthrough infections in MPN-COVID vaccinated patients

Rumi E;Borsani O;
2022-01-01

Abstract

we have provided quantitative estimates of SARSCoV2 infections in vaccinated patients with MPN revealing a higher rate of severe disease than in the normal population. Compared to unvaccinated, a trend for a lower reinfection rate was found in patients with hybrid vaccination.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1477521
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact